Trimethoprim-sulfamethoxazole associated rhabdomyolysis in a patient with AIDS: Case report and review of the literature

American Journal of the Medical Sciences

Volumn 331, Issue 6, 2006, Pages 339-341

  Walker, Steven ^a   Norwood, John ^a,d   Thornton, Camille ^b   Schaberg, Dennis ^c  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE   (United States)

Author keywords

HIV; Rhabdomyolysis; Trimethoprim sulfamethoxazole

Indexed keywords

ATOVAQUONE; COTRIMOXAZOLE; EMTRICITABINE; LEVOFLOXACIN; LOPINAVIR PLUS RITONAVIR; TENOFOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANAMNESIS; CASE REPORT; EMERGENCY WARD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEVER; HOSPITAL DISCHARGE; HUMAN; HYPOXIA; LABORATORY TEST; MALE; MEDICAL LITERATURE; PHYSICAL EXAMINATION; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; REVIEW; RHABDOMYOLYSIS; SINUS TACHYCARDIA; TACHYPNEA; THORAX RADIOGRAPHY; TREATMENT WITHDRAWAL; WESTERN BLOTTING;

EID: 33745226489     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200606000-00011     Document Type: Article

References (12)

1. Chariot P, Ruet E, Authier FJ, et al. Acute rhabdomyolysis in patients infected by human immunodeficiency virus. Neurology 1994;44:1692-6.
2. McDonagh CA, Holman RP. Primary human immunodeficiency virus type 1 infection in a patient with acute rhabdomyolysis. South Med J 2003;96:1027-30.
3. Raestegar D, Clairborne C, Fleisher A, et al. A patient with primary human immunodeficiency virus infection who presented with acute rhabdomyolysis. Clin Infect Dis 2001;32:502-4.
4. Moro H, Tsukada H, Tanuma A, et al. Rhabdomyolysis after simvastatin therapy in an HIV-infected patient. AIDS Patient Care STDS 2004;18:687-90.
5. Hare CB, Vu MP, Grunfeld C, et al. Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death. Clin Infect Dis 2002;35:e111-2.
6. Mah Ming JB, Gill MJ. Drug-induced rhabdomyolysis after concomitant use of clarithromycin, atorvostatin, and lopinavir/ ritonavir in a patient with HIV. AIDS Patient Care STDS 2003;17:207-10.
7. Beversdorf D, Mattison HR. Rhabdomyolysis and the acquired immunodeficiency syndrome. Neurology 1996;46:1498.
8. Anders HJ, Bogner JR, Goebel FD. Mild rhabdomyolysis after high-dose trimethoprim-sulfamethoxazole in a patient with HIV infection. Eur J Med Res 1997;2:198-200.
9. Singer S, Racoosin J, Viraraghavan R. Rhabdomyolysis in human immunodeficiency virus-positive patients taking trimethoprim-sulfamethoxazole. Clin Infect Dis 1998;26:233-4.
10. Arnold PA, Guglielmo BJ, Hollander H. Severe hypersensitivity reaction upon rechallenge with trimethoprim-sulfamethoxazole in a patient with AIDS. Drug Intell Clin Pharm 1988;22:43-5.
11. Conley E. Summary of safety-related drug labeling changes approved by the FDA. MEDWATCH. US Food and Drug Administration fda.gov/MEDWATCH, 1998 November.
12. Guis S, Mattei JP, Cozzone PJ, et al. Pathophysiology and clinical presentations of rhabdomyolysis. Bone Joint Spine 2005;72:382-91.